AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (2.6 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

Causal associations of brain structure with bone mineral density: a large-scale genetic correlation study

Bin Guo1,Chao Wang1,Yong Zhu1Zhi Liu1Haitao Long1Zhe Ruan1Zhangyuan Lin1Zhihua Fan2Yusheng Li1,3( )Shushan Zhao1,3( )
Department of Orthopedics, Xiangya Hospital, Central South University, Changsha 410008 Hunan, China
Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China

These authors contributed equally: Bin Guo, Chao Wang

Show Author Information

Abstract

In this study, we aimed to investigate the causal associations of brain structure with bone mineral density (BMD). Based on the genome-wide association study (GWAS) summary statistics of 1325 brain imaging-derived phenotypes (BIDPs) of brain structure from the UK Biobank and GWAS summary datasets of 5 BMD locations, including the total body, femoral neck, lumbar spine, forearm, and heel from the GEFOS Consortium, linkage disequilibrium score regression (LDSC) was conducted to determine the genetic correlations, and Mendelian randomization (MR) was then performed to explore the causal relationship between the BIDPs and BMD. Several sensitivity analyses were performed to verify the strength and stability of the present MR outcomes. To increase confidence in our findings, we also performed confirmatory MR between BIDPs and osteoporosis. LDSC revealed that 1.93% of BIDPs, with a false discovery rate (FDR) < 0.01, were genetically correlated with BMD. Additionally, we observed that 1.31% of BIDPs exhibited a significant causal relationship with BMD (FDR < 0.01) through MR. Both the LDSC and MR results demonstrated that the BIDPs “Volume of normalized brain,” “Volume of gray matter in Left Inferior Frontal Gyrus, pars opercularis,” “Volume of Estimated Total Intra Cranial” and “Volume-ratio of brain segmentation/estimated total intracranial” had strong associations with BMD. Interestingly, our results showed that more left BIDPs were causally associated with BMD, especially within and around the left frontal region. In conclusion, a part of the brain structure causally influences BMD, which may provide important perspectives for the prevention of osteoporosis and offer valuable insights for further research on the brain-bone axis.

References

1

Lane, N. E. Epidemiology, etiology, and diagnosis of osteoporosis. Am. J. Obstet. Gynecol. 194, S3–S11 (2006).

2

Kelsey, J. L. Risk factors for osteoporosis and associated fractures. Public Health Rep. 104, 14–20 (1989).

3

Black, D. M. & Rosen, C. J. Clinical practice. Postmenopausal osteoporosis. N. Engl. J. Med. 374, 254–262 (2016).

4

Maryanovich, M., Takeishi, S. & Frenette, P. S. Neural regulation of bone and bone marrow. Cold Spring Harb. Perspect Med. 8, a031344 (2018).

5

Adams, H. H. et al. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nat. Neurosci. 19, 1569–1582 (2016).

6

Takano, Y. et al. Hypoperfusion in the posterior cingulate cortex is associated with lower bone mass density in elderly women with osteopenia and Alzheimer’s disease. Clin. Exp. Pharmacol. Physiol. 47, 365–371 (2020).

7

Qin, W., Bauman, W. A. & Cardozo, C. P. Evolving concepts in neurogenic osteoporosis. Curr. Osteoporos. Rep. 8, 212–218 (2010).

8

Roos, P. M. Osteoporosis in neurodegeneration. J. Trace Elem. Med. Biol. 28, 418–421 (2014).

9

Raglione, L. M., Sorbi, S. & Nacmias, B. Osteoporosis and Parkinson’s disease. Clin. Cases Min. Bone Metab. 8, 16–18 (2011).

10

Antoniou, G., Benetos, I. S., Vlamis, J. & Pneumaticos, S. G. Bone mineral density post a spinal cord injury: a review of the current literature guidelines. Cureus 14, e23434 (2022).

11

Caplliure-Llopis, J. et al. Poor bone quality in patients with amyotrophic lateral sclerosis. Front. Neurol. 11, 599216 (2020).

12

Kumar, S. et al. Alzheimer’s disease and its association with bone health: a case-control study. Cureus 13, e13772 (2021).

13

Mohammad, A. F., Khan, K. A., Galvin, L., Hardiman, O. & O’Connell, P. G. High incidence of osteoporosis and fractures in an aging post-polio population. Eur. Neurol. 62, 369–374 (2009).

14

Simonsen, C. S. et al. Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study. BMC Neurol. 16, 252 (2016).

15

Douaud, G. et al. Brain microstructure reveals early abnormalities more than two years prior to clinical progression from mild cognitive impairment to Alzheimer’s disease. J. Neurosci. Off. J. Soc. Neurosci. 33, 2147–2155 (2013).

16

Miller, K. L. et al. Multimodal population brain imaging in the UK Biobank prospective epidemiological study. Nat. Neurosci. 19, 1523–1536 (2016).

17

Alfaro-Almagro, F. et al. Image processing and Quality Control for the first 10,000 brain imaging datasets from UK Biobank. NeuroImage 166, 400–424 (2018).

18

Ma, B. et al. Causal associations of anthropometric measurements with fracture risk and bone mineral density: a mendelian randomization study. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 36, 1281–1287 (2021).

19

Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).

20

Nitsch, D. et al. Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials. Am. J. Epidemiol. 163, 397–403 (2006).

21

Raichle, M. E. & Mintun, M. A. Brain work and brain imaging. Annu. Rev. Neurosci. 29, 449–476 (2006).

22

Blake, G. M. & Fogelman, I. The clinical role of dual energy X-ray absorptiometry. Eur. J. Radio. 71, 406–414 (2009).

23

Huang, S. et al. Neural regulation of bone remodeling: Identifying novel neural molecules and pathways between brain and bone. J. Cell. Physiol. 234, 5466–5477 (2019).

24

Takeda, S. et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 111, 305–317 (2002).

25

Baldock, P. A. et al. Hypothalamic Y2 receptors regulate bone formation. J. Clin. Investig. 109, 915–921 (2002).

26

Harada, S. & Rodan, G. A. Control of osteoblast function and regulation of bone mass. Nature 423, 349–355 (2003).

27

Takeda, S. Osteoporosis: a neuroskeletal disease. Int. J. Biochem. cell Biol. 41, 455–459 (2009).

28

Grodzinsky, Y. & Amunts, K. Broca’s region. (Oxford University Press, 2006).

29

Abdul-Kareem, I. A., Stancak, A., Parkes, L. M. & Sluming, V. Increased gray matter volume of left pars opercularis in male orchestral musicians correlate positively with years of musical performance. J. Magn. Reson. Imaging.: JMRI 33, 24–32 (2011).

30

Iacoboni, M. et al. Cortical mechanisms of human imitation. Science 286, 2526–2528 (1999).

31

Rizzolatti, G. et al. Localization of grasp representations in humans by PET: 1. Observation versus execution. Exp. Brain Res. 111, 246–252 (1996).

32

Binkofski, F. et al. A parieto-premotor network for object manipulation: evidence from neuroimaging. Exp. Brain Res. 128, 210–213 (1999).

33

Krams, M., Rushworth, M. F., Deiber, M. P., Frackowiak, R. S. & Passingham, R. E. The preparation, execution and suppression of copied movements in the human brain. Exp. Brain Res. 120, 386–398 (1998).

34

Koski, L. et al. Modulation of motor and premotor activity during imitation of target-directed actions. Cereb. Cortex 12, 847–855 (2002).

35

Koechlin, E. & Jubault, T. Broca’s area and the hierarchical organization of human behavior. Neuron 50, 963–974 (2006).

36

Stefanidou, M. et al. Bone mineral density measurements and association with brain structure and cognitive function: the framingham offspring cohort. Alzheimer Dis. Assoc. Disord. 35, 291–297 (2021).

37

Woodward, N. D. & Heckers, S. Brain structure in neuropsychologically defined subgroups of schizophrenia and psychotic bipolar disorder. Schizophr. Bull. 41, 1349–1359 (2015).

38

Misra, M., Papakostas, G. I. & Klibanski, A. Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism. J. Clin. Psychiatry 65, 1607–1618 (2004).

39

Williams, L. J. et al. The association between depressive and anxiety symptoms and bone mineral density in the general population: the HUNT Study. J. Affect. Disord. 131, 164–171 (2011).

40

Zhou, R., Deng, J., Zhang, M., Zhou, H. D. & Wang, Y. J. Association between bone mineral density and the risk of Alzheimer’s disease. J. Alzheimer’s Dis. JAD 24, 101–108 (2011).

41

Jung, D. U. et al. Bone mineral density and osteoporosis risk in older patients with schizophrenia. J. Clin. Psychopharmacol. 31, 406–410 (2011).

42

Shan, X. et al. Disrupted regional homogeneity in drug-naive patients with bipolar disorder. Front. Psychiatry 11, 825 (2020).

43

Chandrasekaran, V. et al. Association between bipolar spectrum disorder and bone health: a meta-analysis and systematic review protocol. BMJ Open 7, e013981 (2017).

44

Hsu, C. C. et al. Increased risk of fracture in patients with bipolar disorder: a nationwide cohort study. Soc. Psychiatry Psychiatr. Epidemiol. 51, 1331–1338 (2016).

45

Courchesne, E. et al. Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology 216, 672–682 (2000).

46

Kamdar, M. R., Gomez, R. A. & Ascherman, J. A. Intracranial volumes in a large series of healthy children. Plast. Reconstr. Surg. 124, 2072–2075 (2009).

47

Davis, P. J. M. & Wright, E. A. A new method for measuring cranial cavity volume and its application to the assessment of cerebral atrophy at autopsy. Neuropathol. Appl. Neurobiol. 3, 341–358 (1977).

48

Bae, I. S., Kim, J. M., Cheong, J. H., Han, M. H. & Ryu, J. I. Association between cerebral atrophy and osteoporotic vertebral compression fractures. PLoS One 14, e0224439 (2019).

49

Loskutova, N., Honea, R. A., Vidoni, E. D., Brooks, W. M. & Burns, J. M. Bone density and brain atrophy in early Alzheimer’s disease. J. Alzheimer’s Dis. JAD 18, 777–785 (2009).

50

Bae, I. S., Kim, J. M., Cheong, J. H., Ryu, J. I. & Han, M. H. Association between bone mineral density and brain parenchymal atrophy and ventricular enlargement in healthy individuals. Aging 11, 8217–8238 (2019).

51

Saboori, P. & Sadegh, A. Histology and morphology of the brain subarachnoid trabeculae. Anat. Res. Int. 2015, 279814 (2015).

52

Grant, S. F. et al. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat. Genet. 14, 203–205 (1996).

53

Richard, E. et al. Morphometric changes in the cortical microvascular network in Alzheimer’s disease. J. Alzheimer’s Dis. JAD 22, 811–818 (2010).

54

Miller, V. M. et al. The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned? Menopause 26, 1071–1084 (2019).

55

Wong, I. P., Zengin, A., Herzog, H. & Baldock, P. A. Central regulation of bone mass. Semin. Cell Dev. Biol. 19, 452–458 (2008).

56

Hökfelt, T. et al. Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system. Brain Res. Brain Res. Rev. 26, 154–166 (1998).

57

Lindefors, N., Brené, S., Herrera-Marschitz, M. & Persson, H. Regulation of neuropeptide Y gene expression in rat brain. Ann. N. Y. Acad. Sci. 611, 175–185 (1990).

58

Rogers, L. J. & Andrew, R. Comparative vertebrate lateralization. (Cambridge University Press, 2002).

59

Ocklenburg, S. & Güntürkün, O. Hemispheric asymmetries: the comparative view. Front. Psychol. 3, 5 (2012).

60

Concha, M. L., Signore, I. A. & Colombo, A. Mechanisms of directional asymmetry in the zebrafish epithalamus. Semin. Cell Dev. Biol. 20, 498–509 (2009).

61
Hervé, P.-Y., Zago, L., Petit, L., Mazoyer, B. & Tzourio-Mazoyer, N. J. Revisiting human hemispheric specialization with neuroimaging. Trends Cogn. Sci. 17, 69–80 (2013). T. i. c. s.
62

Gotts, S. J. et al. Two distinct forms of functional lateralization in the human brain. Proc. Natl. Acad. Sci. USA 110, E3435–E3444 (2013).

63

Guadalupe, T. et al. Asymmetry within and around the human planum temporale is sexually dimorphic and influenced by genes involved in steroid hormone receptor activity. Cortex 62, 41–55 (2015).

64

Guadalupe, T. et al. Measurement and genetics of human subcortical and hippocampal asymmetries in large datasets. Hum. Brain Mapp. 35, 3277–3289 (2014).

65

Zhu, D. et al. Total brain volumetric measures and schizophrenia risk: a two-sample mendelian randomization study. Front. Genet. 13, 782476 (2022).

66

van der Sluis, S., Posthuma, D., Nivard, M. G., Verhage, M. & Dolan, C. V. Power in GWAS: lifting the curse of the clinical cut-off. Mol. Psychiatry 18, 2–3 (2013).

67

Elliott, L. T. et al. Genome-wide association studies of brain imaging phenotypes in UK Biobank. Nature 562, 210–216 (2018).

68

Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).

69

Xu, J. et al. Assessing the Association between Important Dietary Habits and Osteoporosis: a genetic correlation and two-sample mendelian randomization study. Nutrients 14, 2656 (2022).

70

Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).

71

Davies, N. M., Holmes, M. V. & Davey Smith, G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 362, k601 (2018).

72

Kamat, M. A. et al. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinforma. (Oxf., Engl.) 35, 4851–4853 (2019).

73

Pagoni, P., Dimou, N. L., Murphy, N. & Stergiakouli, E. Using Mendelian randomisation to assess causality in observational studies. Evid. Based Ment. Health 22, 67–71 (2019).

74

Wang, C. et al. Causal associations of obesity related anthropometric indicators and body compositions with knee and hip arthritis: a large-scale genetic correlation study. Front. Endocrinol. 13, 1011896 (2022).

75

Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512–525 (2015).

76

Hemani, G., Tilling, K. & Davey Smith, G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 13, e1007081 (2017).

77

Armstrong, R. A. When to use the Bonferroni correction. Ophthalmic Physiol. Opt. 34, 502–508 (2014).

78

Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc.: Ser. B Methodol. 57, 289–300 (1995).

Bone Research
Article number: 37
Cite this article:
Guo B, Wang C, Zhu Y, et al. Causal associations of brain structure with bone mineral density: a large-scale genetic correlation study. Bone Research, 2023, 11: 37. https://doi.org/10.1038/s41413-023-00270-z

197

Views

2

Downloads

10

Crossref

6

Web of Science

6

Scopus

Altmetrics

Received: 18 February 2023
Revised: 13 April 2023
Accepted: 22 May 2023
Published: 20 July 2023
© The Author(s) 2023

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Return